Expert Insights On Data Management & Analysis

  1. Tackling AI Copyright Challenges In Pharma And Clinical Research 2/21/2025

    Pistoia Alliance President Becky Upton, Ph.D. explains pharma and clinical research organizations must collaborate to address copyright and data-sharing challenges with or AI — or risk stalling innovation.

  2. A Tool To Tackle The Risk Of Uninformative Trials 1/31/2025

    Uninformative trials hinder progress in clinical practice, policy decisions, and further research. Fast Data Science developed a free risk tool to help pharma companies avoid them.

  3. Using Critical To Quality (CtQ) Factors To Identify The Critical Data For RBQM 1/2/2025

    Based on ICH E8(R1) quality by design (QbD) principles, experts explain the use of critical to quality (CtQ) factors to identify critical data that focuses the end-to-end RBQM process on patient safety and trial results.

  4. What Future Laboratory Manuals Should Look Like 12/20/2024

    In the final article of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair imagines what the perfect lab manual might look like — and how to make it a reality.

  5. How Laboratory Manuals Fail Sites And Sponsors 12/19/2024

    In part one of this series, FlexPoint Bio Founder and CEO Elena Sinclair describes the hazards of poorly designed (and followed) clinical trial lab manuals.

  6. Lab Manual Gaps: Sabotaging Data One Sample At A Time 12/19/2024

    In part two of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair discusses the criticality of sample and process quality.

  7. How Did Clinical Researchers Actually Use AI In 2024? 12/5/2024

    Looking ahead to 2025, Clinical Leader seeks to understand how clinical research professionals are incorporating AI into their work. So we asked them, “Simply put: Are you using any iteration of AI in your role within clinical research? If so, how and why?”

  8. Pondering The "What Ifs" Of Inspection Readiness With Generative AI 12/4/2024

    Just In Time GCP Founder and CEO Donna Dorozinsky contemplates some of the developing uses of generative AI for inspection readiness.

  9. A Data-Driven Approach That Could Change Mental Healthcare In 2025… And Beyond 12/2/2024

    Heterogeneity of patient populations combined with subjective clinical interpretation often results in imprecise treatments, frustrated patients, and poor outcomes, says Greg Hajcak, Ph.D. Here, he argues for a data-driven approach, also called “precision psychiatry,” to personalize clinical trials and care.

  10. Seeing Firsthand The Transformative Impact Of AI On Pharmacovigilance And Clinical Research 11/27/2024

    Consultants Aashna Goyal and Guriqbal Singh share first-persona accounts of how AI is transforming pharmacovigilance and clinical research by improving data processing, enhancing decision-making, and accelerating drug development.